Genmab — Juli 2020

[bibob]

Fra Fierce Biotec. https://www.fiercebiotech.com/biotech/genmab-seattle-genetics-eye-fda-filing-after-seeing-cancer-data?mkt_tok=eyJpIjoiTURWalpEa3pOakZqTUdZdyIsInQiOiJicSswNElyNTFpbWhrcWlwUEF0Z3FncllNc0lncGhXSmpKY2pCRytBbEtrZjJOOVpvbGRFZ3k0TkJnUG9SRkVYZUpFZmRhbEZWbndHZVFHaTMzV3lQMXE2a2FuQ3BwR0xjaTNBUVVSUUl5dlNXeEdieHNONjZtR2VlSkJSUDc5OEVpck8ySW9xbHJEMEcrU2VtTWE3cmc9PSJ9&mrkid=41140432

[Legolas23]

Nyheden fra i går i nye medier?

[E_L]

So do we think Jan will sell some shares today? My guess is about 50.000 of those shares are his which would be a nice round number for a sale

[Solsen]

Could be the case. The 35.000 warrannts/shares at 66,6 could very well be JWs.

[E_L]

+100 +7.200 +7.700 = 50.000

[E_L]

I admit I was a bit bored this morning

[E_L]

UBS Reiterates Buy Rating

[Bulder]

still 2500?

[GeorgeBest]

yes

[GeorgeBest]

AlphaValue increase target on Genmab to 2213, but keeps reduce rating

[E_L]

Multiagent therapy with pomalidomide, bortezomib, doxorubicin, dexamethasone, and daratumumab (“Pom‐PAD‐Dara”) in relapsed/refractory multiple myeloma https://onlinelibrary.wiley.com/doi/abs/10.1002/cam4.3209

[E_L]

CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2020006200/461232/CD38-deletion-of-human-primary-NK-cells-eliminates?redirectedFrom=fulltext

[Sibelius]

Er der en af "nørderne" herinde der måske kunne hjælpe mig med at finde readouts/resultater på et fase tre studie der hedder Checkmate 214 (Bristol-Meyers Squibb?

[Sibelius]

Jeg er åbenbart selv en "Nørd" - har fundet det:-)

[gdn55]

Tænk på hvor meget den er steget. Men det er selvfølgelig ikke godt når den falder. Kunne være rart med en aktie der kun kan stige.

[GeorgeBest]

UPDATE 1-BioNTech and Pfizer's COVID-19 vaccine shows potential in human trial - Reuters News

[Stroka]

Kl. 15,33 dykkede den pludseligt pga af et mindre udsalg. Troede at warrantssalget var overstået.

[E_L]

that is in principle not for Genmab to arrange. The shares go to the staff and they decide if they sell into the market or not.

[Solsen]

Genmab kan ikke forventes at stige hver dag. Det var ønskeligt, men vi er måske ved vejs ende for en stund. Men hvilket afkast i år indtil nu.

[gdn55]

Indtil videre er den steget med ca. en 50 i denne uge, så ingen grund til panik.